Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:855-860
Published online before print February 2, 2004, doi: 10.1161/01.CIR.0000116389.61864.DE
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/7/855    most recent
01.CIR.0000116389.61864.DEv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, C. D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diabetes
*Heart Attack
Related Collections
Right arrow Risk Factors
Right arrow Type 2 diabetes
Right arrow Acute myocardial infarction
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology

(Circulation. 2004;109:855-860.)
© 2004 American Heart Association, Inc.


Clinical Investigation and Reports

Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction

Chong Do Lee, EdD; Aaron R. Folsom, MD; James S. Pankow, PhD; Frederick L. Brancati, MD, For the Atherosclerosis Risk in Communities (ARIC) Study Investigators

From the Department of Sports and Exercise Sciences (C.D.L.), West Texas A&M University, Canyon, Tex; Division of Epidemiology (A.R.F., J.S.P.), School of Public Health, University of Minnesota, Minneapolis, Minn; and Departments of Medicine and Epidemiology (F.L.B.), Johns Hopkins University, Baltimore, Md.

Correspondence to Dr Aaron Folsom, Division of Epidemiology, School of Public Health, University of Minnesota, 1300 South 2nd Street, Suite 300, Minneapolis, MN 55454-1015. E-mail folsom{at}epi.umn.edu

Received July 15, 2003; de novo received October 14, 2003; accepted November 21, 2003.

Background— Whether diabetic patients without a history of myocardial infarction (MI) have the same risk of coronary heart disease (CHD) events as nondiabetic patients with a history of MI remains controversial. We compared risks of CHD and stroke events and mortality from cardiovascular disease (CVD) in diabetic and nondiabetic men and women with and without a history of MI.

Methods and Results— We followed a total of 13 790 African American and white men and women ages 45 to 64 years who participated in the Atherosclerosis Risk in Communities study, beginning in 1987 to 1989. There were 634 fatal CHD or nonfatal MI events, 312 fatal or nonfatal strokes, and 358 deaths from CVD during an average of 9 years of follow-up (125 998 person-years). After adjustment for age, sex, race, Atherosclerosis Risk in Communities field center, and multiple baseline risk factors, patients who had a history of MI without diabetes at baseline had 1.9 times the risk of fatal CHD or nonfatal MI (95% CI, 1.35 to 2.56; P<0.001) compared with diabetic patients without a prior history of MI. The nondiabetic patients with MI also had 1.8 times the risk of CVD mortality compared with diabetic patients without MI (95% CI, 1.22 to 2.72; P=0.003). However, stroke risk was similar between diabetic patients without MI and nondiabetic patients with MI (RR, 1.05; 95% CI, 0.61 to 1.79; P=0.87). We also observed that nondiabetic patients with MI had a carotid artery wall thickness similar to diabetic patients without MI (P=0.77).

Conclusions— Diabetic patients without MI had lower risk of CHD events and mortality from CVD compared with nondiabetic patients with MI, but stroke risk was similar between these 2 groups.


Key Words: diabetes mellitus • myocardial infarction • stroke • cardiovascular diseases




This article has been cited by other articles:


Home page
CirculationHome page
S. W. Worm, S. De Wit, R. Weber, C. A. Sabin, P. Reiss, W. El-Sadr, A. D. Monforte, O. Kirk, E. Fontas, F. Dabis, et al.
Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)
Circulation, February 17, 2009; 119(6): 805 - 811.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. R. Dagenais MD, A. St-Pierre PhD, P. Gilbert MD, B. Lamarche PhD, J.-P. Despres PhD, P.-M. Bernard MSc, and P. Bogaty MD
Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease
Can. Med. Assoc. J., January 6, 2009; 180(1): 40 - 47.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. Mauldin, M. H. Nagelin, A. J. Wojcik, S. Srinivasan, M. D. Skaflen, C. R. Ayers, C. A. McNamara, and C. C. Hedrick
Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus
Circulation, May 27, 2008; 117(21): 2785 - 2792.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Palmas, T. G. Pickering, J. Teresi, J. E. Schwartz, L. Field, R. S. Weinstock, and S. Shea
Telemedicine Home Blood Pressure Measurements and Progression of Albuminuria in Elderly People With Diabetes
Hypertension, May 1, 2008; 51(5): 1282 - 1288.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. K. Schramm, G. H. Gislason, L. Kober, S. Rasmussen, J. N. Rasmussen, S. Z. Abildstrom, M. L. Hansen, F. Folke, P. Buch, M. Madsen, et al.
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People
Circulation, April 15, 2008; 117(15): 1945 - 1954.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Peter, A Cox, and M Evans
Management of diabetes in cardiovascular patients
Heart, March 1, 2008; 94(3): 369 - 375.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. C. Dale, T. I. Nilsen, L. Vatten, K. Midthjell, and R. Wiseth
Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74 914 individuals in the HUNT 1 Study
Eur. Heart J., December 1, 2007; 28(23): 2924 - 2929.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Singh, Y. K. Loke, and C. D. Furberg
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
JAMA, September 12, 2007; 298(10): 1189 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Nicolucci, G. De Berardis, M. Sacco, and G. Tognoni
AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions
Eur. Heart J., August 2, 2007; 28(16): 1925 - 1927.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. H. W. Gowdak, F. J. de Paula, L. A. M. Cesar, E. E. M. Filho, L. E. Ianhez, E. M. Krieger, J. A. F. Ramires, and J. J. G. De Lima
Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1456 - 1461.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Avogaro, C. Giorda, M. Maggini, E. Mannucci, R. Raschetti, F. Lombardo, S. Spila-Alegiani, S. Turco, M. Velussi, E. Ferrannini, et al.
Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women: Impact of microvascular complications, treatment, and geographic location
Diabetes Care, May 1, 2007; 30(5): 1241 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
R. Saracci
Survival-related biases survive well
Int. J. Epidemiol., February 1, 2007; 36(1): 244 - 246.
[Full Text] [PDF]


Home page
CirculationHome page
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al.
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association
Circulation, January 2, 2007; 115(1): 114 - 126.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al.
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association
Diabetes Care, January 1, 2007; 30(1): 162 - 172.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
G. Steiner
Implications of the global diabetes epidemic
Diabetes and Vascular Disease Research, September 1, 2006; 3(1_suppl): S2 - S5.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Bax, R. O. Bonow, D. Tschope, S. E. Inzucchi, E. Barrett, and on behalf of the Global Dialogue Group for the Eva
The Potential of Myocardial Perfusion Scintigraphy for Risk Stratification of Asymptomatic Patients With Type 2 Diabetes
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 754 - 760.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. A.M. Zandbergen, E. J. Sijbrands, S. W. Lamberts, and A. H. Bootsma
Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease
Diabetes Care, August 1, 2006; 29(8): 1851 - 1855.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. H. Knopp, M. d'Emden, J. G. Smilde, S. J. Pocock, and on behalf of the ASPEN Study Group
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
Diabetes Care, July 1, 2006; 29(7): 1478 - 1485.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
B. J. Witt, R. D. Brown Jr., S. J. Jacobsen, S. A. Weston, B. P. Yawn, and V. L. Roger
A Community-Based Study of Stroke Incidence after Myocardial Infarction
Ann Intern Med, December 6, 2005; 143(11): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Juutilainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso
Type 2 Diabetes as a "Coronary Heart Disease Equivalent": An 18-year prospective population-based study in Finnish subjects
Diabetes Care, December 1, 2005; 28(12): 2901 - 2907.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Inflammation, Atherosclerosis, and Aspects of Insulin Action
Diabetes Care, September 1, 2005; 28(9): 2312 - 2319.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Hu, P. Jousilahti, Q. Qiao, M. Peltonen, S. Katoh, and J. Tuomilehto
The Gender-Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease
J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1413 - 1418.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. D. Flaherty and C. J. Davidson
Diabetes and Coronary Revascularization
JAMA, March 23, 2005; 293(12): 1501 - 1508.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L.M. Stevens, M. Carrier, L.P. Perrault, Y. Hebert, R. Cartier, D. Bouchard, A. Fortier, and M. Pellerin
Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting
Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 281 - 288.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Boccara and A Cohen
Interplay of diabetes and coronary heart disease on cardiovascular mortality
Heart, December 1, 2004; 90(12): 1371 - 1373.
[Abstract] [Full Text] [PDF]